Analysis of serum chemokine levels in patients with HIV-associated eosinophilic folliculitis

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 2, 2013, Pages

  Yokobayashi, H ^a   Sugaya, M ^a,b   Miyagaki, T ^b   Kai, H ^a,b   Suga, H ^a,b   Yamada, D ^a,b   Minatani, Y ^a,b   Watanabe, K ^a   Kikuchi, Y ^a   Tamaki, T ^a   Sato, S ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CUTANEOUS T CELL ATTRACTING CHEMOKINE; EOTAXIN; EOTAXIN 3; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONDYLOMA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL FOLLICULITIS; FEMALE; FOLLICULITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PAPULAR RASH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PRURITIC PAPULAR ERUPTION;

CD4 LYMPHOCYTE COUNT; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FOLLICULITIS; HIV INFECTIONS; HUMANS; SKIN DISEASES, VESICULOBULLOUS;

EID: 84872675610     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04592.x     Document Type: Article

References (30)

1. Tschachler E, Bergstresser PR, Stingl G,. HIV-related skin diseases. Lancet 1996; 348: 659-663.
2. Cedeno-Laurent F, Gõmez-Flores M, Mendez N, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc 2011; 14: 5.
3. Soeprono FF, Schinella RA,. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases. J Am Acad Dermatol 1986; 14: 1020-1022.
4. Rosenthal D, LeBoit PE, Klumpp L, Berger TG,. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol 1991; 127: 206-209.
5. Hevia O, Jimenez-Acosta F, Ceballos PI, Gould EW, Penneys NS,. Pruritic papular eruption of the acquired immunodeficiency syndrome: a clinicopathologic study. J Am Acad Dermatol 1991; 24: 231-235.
6. Budavari JM, Grayson W,. Papular follicular eruptions in human immunodeficiency virus-positive patients in South Africa. Int J Dermatol 2007; 46: 706-710.
7. Misago N, Narisawa Y, Matsubara S, Hayashi S,. HIV-associated eosinophilic pustular folliculitis: successful treatment of a Japanese patient with UVB phototherapy. J Dermatol 1998; 25: 178-184.
8. Blauvelt A, Plott RT, Spooner K, Stearn B, Davey RT, Turner ML,. Eosinophilic folliculitis associated with the acquired immunodeficiency syndrome responds well to permethrin. Arch Dermatol 1995; 131: 360-361.
9. Majors MJ, Berger TG, Blauvelt A, Smith KJ, Turner ML, Cruz PD Jr,. HIV-related eosinophilic folliculitis: a panel discussion. Semin Cutan Med Surg 1997; 16: 219-223.
10. Resneck JS Jr, Van Beek M, Furmanski L, et al. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA 2004; 292: 2614-2621.
11. Amerio P, Verdolini R, Proietto G, et al. Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis. Acta Derm Venereol 2001; 81: 92-95.
12. Charo IF, Ransohoff RM,. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-621.
13. Saeki H, Tamaki K,. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006; 43: 75-84.
14. Morales J, Homey B, Vicari AP, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999; 96: 14470-14475.
15. Homey B, Alenius H, Müller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8: 157-165.
16. Forssmann U, Uguccioni M, Loetscher P, et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997; 185: 2171-2176.
17. Sallusto F, Mackay CR, Lanzavecchia A,. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005-2007.
18. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S,. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 2001; 293: 350-355.
19. Yawalkar N, Uguccioni M, Schärer J, et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999; 113: 43-48.
20. Kakinuma T, Wakugawa M, Nakamura K, Hino H, Matsushima K, Tamaki K,. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Br J Dermatol 2003; 148: 203-210.
21. Yokobayashi H, Sugaya M, Miyagaki T, Kai H, Minatani Y, Tamaki T,. Serum chemokine levels in a case of angio-oedema associated with eosinophilia. Br J Dermatol 2008; 159: 738-740.
22. Kakinuma T, Saeki H, Tsunemi Y, et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003; 111: 592-597.
23. Kakinuma T, Nakamura K, Wakugawa M, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107: 535-541.
24. Nakahigashi K, Doi H, Otsuka A, et al. PGD(2) induces eotaxin-3 via PPARγ from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis. J Allergy Clin Immunol 2012; 129: 536-543.
25. Kawamura T, Gulden FO, Sugaya M, et al. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc Natl Acad Sci U S A 2003; 100: 8401-8406.
26. Choe H, Farzan M, Sun Y, et al. The ß-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cel 1996; 85: 1135-1148.
27. He J, Chen Y, Farzan M, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997; 385: 645-649.
28. Kraynyak KA, Kutzler MA, Cisper NJ, et al. Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques. Vaccine 2010; 28: 1942-1951.
29. Ancuta P, Autissier P, Wurcel A, Zaman T, Stone D, Gabuzda D,. CD16+ monocyte-derived macrophages activate resting T cells for HIV infection by producing CCR3 and CCR4 ligands. J Immunol 2006; 176: 5760-5771.
30. Uthayakumar S, Nandwani R, Drinkwater T, Nayagam AT, Darley CR,. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. Br J Dermatol 1997; 137: 595-598.